4/12/13 Contest Update
Are investors dumping Bitcoins and gold to buy biotechs? Well, wherever the money may be coming from it sure looks like our favorite sector is getting a sizeable chunk of it.
At Friday’s close, the Contest median was up 21.33% YTD (vs. up 15.82% YTD a week ago), while the Nasdaq Biotech Index was up 23.34% (vs. up 16.69% YTD a week ago) and the Nasdaq Composite Index was up 9.12% YTD (vs. up 6.11% YTD a week ago).
Nourished by a slice of ACAD, BLADE’s portfolio, up 52.59% YTD, cut in front of the line to take the Contest lead. Also getting an ACAD boost, FILO’s portfolio, up 50.19% YTD, moved to second place and RKRW’s portfolio, up 47.45% YTD, slipped to third place.
At Friday's close, an impressive 37 of the 39 Contest portfolios were in the black with 18 of the 39 now beating the NBI.
Below is the Top Ten list. Also below are the Top 5 & Bottom 5 Stocks ranked by % Gained and % Lost for the week.
Portfolio adjustments: CRME 1-5 reverse split
Have a wonderful spring weekend biotechies!
(All corrections, especially adjustments for splits, greatly appreciated.)
Peace & good health,
Bulba
4/12/13
Rank Name Profit/Loss
1 BLADE 52,592
2 FILO 50,190
3 RKRW 47,453
4 MCBIO 42,516
5 BIOJIM 40,926
6 NIGEL 37,199
7 STEVEL 34,439
8 TOMP 33,983
9 ARTHUR 33,697
10 MOPGCW 33,383
Week's Top 5 Gainers
Symbol 4/5/13 4/12/13 Wk.%chg.
ACAD 7.70 12.54 62.86%
ACRX 5.03 6.03 19.88%
ABLX.BR 5.98 7.11 18.90%
ASTX 5.39 6.38 18.37%
NVIV 2.80 3.30 17.86%
Week's Worst 5 Losers
Symbol 4/5/13 4/12/13 Wk.%chg.
INFI 46.56 40.440 -13.14%
SSH 6.10 5.310 -12.95%
GNVC 1.37 1.210 -11.68%
QCOR 31.50 28.260 -10.29%
SKBI 1.71 1.550 -9.36% |
